Scholar Rock (SRRK)
(Delayed Data from NSDQ)
$9.15 USD
-0.13 (-1.40%)
Updated Jul 29, 2024 04:00 PM ET
After-Market: $9.13 -0.02 (-0.22%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Brokerage Reports
0 items in cart
Scholar Rock Holding Corporation [SRRK]
Reports for Purchase
Showing records 101 - 120 ( 134 total )
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
SRK-015 Highlighted at CURE SMA: Awaiting Key Ph 2 TOPAZ Readout Q4:20
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
1Q20; COVID-19 Delays TOPAZ Readout, but Note Positive SRK-181 Developments
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
From Underneath The Rubble Sing a Rebel Song
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
Worries for Another Day, Let the Music Play, Down in Scholar Rock
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
Topline PK/PD SRK-015 Data in TOPAZ Looks Good, Efficacy in 1H20
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
3Q19 Financials; Preliminary TOPAZ Data up Next by YE19, More to Follow in 2020
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D